- Home
- GNLX vs OPRX Comparison
GNLX vs OPRX Comparison
Compare GNLX & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNLX
- OPRX
- Stock Information
- Founded
- GNLX 2001
- OPRX 2006
- Country
- GNLX United States
- OPRX United States
- Employees
- GNLX N/A
- OPRX N/A
- Industry
- GNLX Biotechnology: Pharmaceutical Preparations
- OPRX Business Services
- Sector
- GNLX Health Care
- OPRX Consumer Discretionary
- Exchange
- GNLX Nasdaq
- OPRX Nasdaq
- Market Cap
- GNLX 184.4M
- OPRX 154.9M
- IPO Year
- GNLX 2023
- OPRX N/A
- Fundamental
- Price
- GNLX $2.96
- OPRX $9.99
- Analyst Decision
- GNLX Strong Buy
- OPRX Buy
- Analyst Count
- GNLX 4
- OPRX 8
- Target Price
- GNLX $17.75
- OPRX $9.06
- AVG Volume (30 Days)
- GNLX 138.3K
- OPRX 147.0K
- Earning Date
- GNLX 05-06-2025
- OPRX 05-12-2025
- Dividend Yield
- GNLX N/A
- OPRX N/A
- EPS Growth
- GNLX N/A
- OPRX N/A
- EPS
- GNLX N/A
- OPRX N/A
- Revenue
- GNLX N/A
- OPRX $92,127,000.00
- Revenue This Year
- GNLX N/A
- OPRX $12.12
- Revenue Next Year
- GNLX N/A
- OPRX $10.87
- P/E Ratio
- GNLX N/A
- OPRX N/A
- Revenue Growth
- GNLX N/A
- OPRX 28.81
- 52 Week Low
- GNLX $1.60
- OPRX $3.78
- 52 Week High
- GNLX $5.89
- OPRX $14.13
- Technical
- Relative Strength Index (RSI)
- GNLX 54.28
- OPRX 66.74
- Support Level
- GNLX $2.26
- OPRX $9.12
- Resistance Level
- GNLX $3.06
- OPRX $10.40
- Average True Range (ATR)
- GNLX 0.31
- OPRX 0.64
- MACD
- GNLX 0.04
- OPRX 0.06
- Stochastic Oscillator
- GNLX 78.42
- OPRX 82.25
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.
About OPRX OptimizeRx Corporation
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.